Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease

Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease Gene Therapy and Regulation , Vol. 2, No. 4, pp. 283 – 300 (2004)  VSP 2004. Also available online - www.vsppub.com Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease ∗ MATTHEW V. CANNON 1 , CARL A. PINKERT 1 , † and IAN A. TROUNCE 2 , † 1 University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Center for Aging and Developmental Biology, Rochester NY, USA 2 University of Melbourne, Centre for Neuroscience, Victoria, Australia Received 10 February 2005; revised 2 March 2005 Abstract —The characterization of mitochondrial diseases has proceeded rapidly since the first descriptions of mitochondrial DNA (mtDNA)-linked disease mutations appeared in the late 1980s. To elucidate mechanisms of a variety of mitochondrial disorders and disease, both in vitro and in vivo modeling systems have been exploited. To produce these models, numerous approaches have been undertaken due to the difficulty associated with targeted mutagenesis and directed modification of the mitochondrial genome. Currently available models of mitochondrial disease are discussed in this paper, including our xenomitochondrial mice. In this model, mitochondria from one donor species are transferred to another. By doing so, cells and animals were generated with varying http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Gene Therapy and Regulation Brill

Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease

Loading next page...
 
/lp/brill/xenomitochondrial-embryonic-stem-cells-and-mice-modeling-human-x3ePt8CV4r

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Brill
Copyright
© 2004 Koninklijke Brill NV, Leiden, The Netherlands
ISSN
1388-9532
eISSN
1568-5586
DOI
10.1163/1568558043967454
Publisher site
See Article on Publisher Site

Abstract

Gene Therapy and Regulation , Vol. 2, No. 4, pp. 283 – 300 (2004)  VSP 2004. Also available online - www.vsppub.com Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease ∗ MATTHEW V. CANNON 1 , CARL A. PINKERT 1 , † and IAN A. TROUNCE 2 , † 1 University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Center for Aging and Developmental Biology, Rochester NY, USA 2 University of Melbourne, Centre for Neuroscience, Victoria, Australia Received 10 February 2005; revised 2 March 2005 Abstract —The characterization of mitochondrial diseases has proceeded rapidly since the first descriptions of mitochondrial DNA (mtDNA)-linked disease mutations appeared in the late 1980s. To elucidate mechanisms of a variety of mitochondrial disorders and disease, both in vitro and in vivo modeling systems have been exploited. To produce these models, numerous approaches have been undertaken due to the difficulty associated with targeted mutagenesis and directed modification of the mitochondrial genome. Currently available models of mitochondrial disease are discussed in this paper, including our xenomitochondrial mice. In this model, mitochondria from one donor species are transferred to another. By doing so, cells and animals were generated with varying

Journal

Gene Therapy and RegulationBrill

Published: Jan 1, 2004

Keywords: MITOCHONDRIA; TRANSGENIC ANIMALS; RHODAMINE-6G; GENE TRANSFER; GENETIC ENGINEERING; EMBRYONIC STEM CELLS; HETEROPLASMY

There are no references for this article.